NIMH NCDDG U01: Cooperative Drug & Device Discovery for Mental Disorders (Clinical Trial Optional)
This NIMH U01 opportunity supports multidisciplinary academic–industry cooperative groups (NCDDGs) to discover and advance novel drugs, biologics, and neuromodulation devices for mental disorders. Funding can support work from target/ligand discovery through preclinical development and first‑in‑human or Phase I studies, emphasizing safety, target engagement, PK/PD, and biomarker development; p…
Source
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers